BACKGROUND AND OBJECTIVES: Electronic personal health records (PHRs) allow patients access to their medical records, self-management tools, and new avenues of communication with their health care providers.
FDA issues guidance on antioxidants. The US Food and Drug Administration (FDA) has published guidance to help small companies comply with the labeling of antioxidant products and high potency products. The Small Entity Compliance Guide sets out the agencyâs position âin plain languageâ regarding the use of the nutrient content claims on dietary supplement products.
Anticoagulants (sometimes known as âblood thinnersâ) are medicines that delay the clotting of blood. Examples are heparin, warfarin, dabigitran, apixaban, and rivoraxaban. Anticoagulants make it harder for clots to form or. keep existing clots from growing in your heart, veins. or arteries. Treatment should be managed by your. healthcare provider.